CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, announced today that its proprietary gamma sensory stimulation at 40Hz over a 6-month period reduced white matter atrophy in the brain for ...

At the forefront of this shift is Nuropod, a U.S.-available, non-invasive, ear-worn vagus nerve stimulation wearable designed ...

Simple 40-hertz light and sound stimulation can induce brain rhythms that reduce Alzheimer’s pathology and improve cognitive function without invasive procedures or pharmaceutical side effects.

Evidence that non-invasive sensory stimulation of 40 Hz gamma frequency brain rhythms can reduce Alzheimer's disease pathology and symptoms, already shown with light and sound by multiple research ...

Diane Chan (left) and Li-Huei Tsai (right) discuss the research in MIT lab where volunteers receive 40Hz stimulation and their response is measured using EEG. A new research paper documents the ...

Li-Huei Tsai speaks about the latest gamma rhythm sensory stimulation research in her lab at an MIT colloquium Feb. 27, 2025. A decade after scientists in The Picower Institute for Learning and Memory ...

Cognito Therapeutics, a neurotechnology company birthed out of MIT, is pioneering breakthrough technology that may be able to slow the progression of Alzheimer’s and restore cognition. More than 55 ...

- Long-term, daily proprietary gamma sensory stimulation was shown to be safe and well tolerated; treatment integrated well into subjects' daily lives. - Pivotal trials will launch this year to ...